Global Arginase Deficiency Therapeutics Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Arginase Deficiency Therapeutics Market Research Report 2024

Argininemia, also called arginase deficiency, is an autosomal recessive urea cycle disorder where adeficiency of the enzyme arginase causes a buildup of arginine and ammonia in the blood.
According to MRAResearch’s new survey, global Arginase Deficiency Therapeutics market is projected to reach US$ 137 million in 2033, increasing from US$ 102.5 million in 2022, with the CAGR of 4.2% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Arginase Deficiency Therapeutics market research.
The Arginase deficiency drugs market is driven by the growing awareness and diagnosis of this rare genetic disorder. As understanding of the disease improves, more patients are being identified and seeking treatment options. The development of targeted therapies to address the underlying metabolic abnormalities associated with Arginase deficiency has also contributed to market growth. Additionally, government initiatives and orphan drug designations have facilitated research and development in this area. However, the market faces challenges like limited patient populations, high treatment costs, and the need for specialized medical expertise for diagnosis and management. Overcoming these challenges through increased awareness, early diagnosis, and affordable access to therapies will be essential for the sustained growth of the Arginase deficiency drugs market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Arginase Deficiency Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

Helsinn Healthcare
Novartis Pharmaceuticals
Horizon Pharma
Medicis Pharmaceutical
Segment by Type
Oral
Injection

Segment by Application

Hospital
Drugs Stores
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Arginase Deficiency Therapeutics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Arginase Deficiency Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Arginase Deficiency Therapeutics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Drugs Stores
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Arginase Deficiency Therapeutics Market Perspective (2018-2033)
2.2 Arginase Deficiency Therapeutics Growth Trends by Region
2.2.1 Global Arginase Deficiency Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Arginase Deficiency Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Arginase Deficiency Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Arginase Deficiency Therapeutics Market Dynamics
2.3.1 Arginase Deficiency Therapeutics Industry Trends
2.3.2 Arginase Deficiency Therapeutics Market Drivers
2.3.3 Arginase Deficiency Therapeutics Market Challenges
2.3.4 Arginase Deficiency Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Arginase Deficiency Therapeutics Players by Revenue
3.1.1 Global Top Arginase Deficiency Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Arginase Deficiency Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Arginase Deficiency Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Arginase Deficiency Therapeutics Revenue
3.4 Global Arginase Deficiency Therapeutics Market Concentration Ratio
3.4.1 Global Arginase Deficiency Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Arginase Deficiency Therapeutics Revenue in 2022
3.5 Arginase Deficiency Therapeutics Key Players Head office and Area Served
3.6 Key Players Arginase Deficiency Therapeutics Product Solution and Service
3.7 Date of Enter into Arginase Deficiency Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Arginase Deficiency Therapeutics Breakdown Data by Type
4.1 Global Arginase Deficiency Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Arginase Deficiency Therapeutics Forecasted Market Size by Type (2024-2033)
5 Arginase Deficiency Therapeutics Breakdown Data by Application
5.1 Global Arginase Deficiency Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Arginase Deficiency Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Arginase Deficiency Therapeutics Market Size (2018-2033)
6.2 North America Arginase Deficiency Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Arginase Deficiency Therapeutics Market Size by Country (2018-2023)
6.4 North America Arginase Deficiency Therapeutics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Arginase Deficiency Therapeutics Market Size (2018-2033)
7.2 Europe Arginase Deficiency Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Arginase Deficiency Therapeutics Market Size by Country (2018-2023)
7.4 Europe Arginase Deficiency Therapeutics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Arginase Deficiency Therapeutics Market Size (2018-2033)
8.2 Asia-Pacific Arginase Deficiency Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Arginase Deficiency Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Arginase Deficiency Therapeutics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Arginase Deficiency Therapeutics Market Size (2018-2033)
9.2 Latin America Arginase Deficiency Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Arginase Deficiency Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Arginase Deficiency Therapeutics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Arginase Deficiency Therapeutics Market Size (2018-2033)
10.2 Middle East & Africa Arginase Deficiency Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Arginase Deficiency Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Arginase Deficiency Therapeutics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Helsinn Healthcare
11.1.1 Helsinn Healthcare Company Detail
11.1.2 Helsinn Healthcare Business Overview
11.1.3 Helsinn Healthcare Arginase Deficiency Therapeutics Introduction
11.1.4 Helsinn Healthcare Revenue in Arginase Deficiency Therapeutics Business (2018-2023)
11.1.5 Helsinn Healthcare Recent Development
11.2 Novartis Pharmaceuticals
11.2.1 Novartis Pharmaceuticals Company Detail
11.2.2 Novartis Pharmaceuticals Business Overview
11.2.3 Novartis Pharmaceuticals Arginase Deficiency Therapeutics Introduction
11.2.4 Novartis Pharmaceuticals Revenue in Arginase Deficiency Therapeutics Business (2018-2023)
11.2.5 Novartis Pharmaceuticals Recent Development
11.3 Horizon Pharma
11.3.1 Horizon Pharma Company Detail
11.3.2 Horizon Pharma Business Overview
11.3.3 Horizon Pharma Arginase Deficiency Therapeutics Introduction
11.3.4 Horizon Pharma Revenue in Arginase Deficiency Therapeutics Business (2018-2023)
11.3.5 Horizon Pharma Recent Development
11.4 Medicis Pharmaceutical
11.4.1 Medicis Pharmaceutical Company Detail
11.4.2 Medicis Pharmaceutical Business Overview
11.4.3 Medicis Pharmaceutical Arginase Deficiency Therapeutics Introduction
11.4.4 Medicis Pharmaceutical Revenue in Arginase Deficiency Therapeutics Business (2018-2023)
11.4.5 Medicis Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Arginase Deficiency Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Global Arginase Deficiency Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Arginase Deficiency Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Arginase Deficiency Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Arginase Deficiency Therapeutics Market Share by Region (2018-2023)
Table 8. Global Arginase Deficiency Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Arginase Deficiency Therapeutics Market Share by Region (2024-2033)
Table 10. Arginase Deficiency Therapeutics Market Trends
Table 11. Arginase Deficiency Therapeutics Market Drivers
Table 12. Arginase Deficiency Therapeutics Market Challenges
Table 13. Arginase Deficiency Therapeutics Market Restraints
Table 14. Global Arginase Deficiency Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Arginase Deficiency Therapeutics Market Share by Players (2018-2023)
Table 16. Global Top Arginase Deficiency Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Arginase Deficiency Therapeutics as of 2022)
Table 17. Ranking of Global Top Arginase Deficiency Therapeutics Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Arginase Deficiency Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Arginase Deficiency Therapeutics Product Solution and Service
Table 21. Date of Enter into Arginase Deficiency Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Arginase Deficiency Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Arginase Deficiency Therapeutics Revenue Market Share by Type (2018-2023)
Table 25. Global Arginase Deficiency Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Arginase Deficiency Therapeutics Revenue Market Share by Type (2024-2033)
Table 27. Global Arginase Deficiency Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Arginase Deficiency Therapeutics Revenue Market Share by Application (2018-2023)
Table 29. Global Arginase Deficiency Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Arginase Deficiency Therapeutics Revenue Market Share by Application (2024-2033)
Table 31. North America Arginase Deficiency Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Arginase Deficiency Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Arginase Deficiency Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Arginase Deficiency Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Arginase Deficiency Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Arginase Deficiency Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Arginase Deficiency Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Arginase Deficiency Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Arginase Deficiency Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Arginase Deficiency Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Arginase Deficiency Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Arginase Deficiency Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Arginase Deficiency Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Arginase Deficiency Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Arginase Deficiency Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 46. Helsinn Healthcare Company Detail
Table 47. Helsinn Healthcare Business Overview
Table 48. Helsinn Healthcare Arginase Deficiency Therapeutics Product
Table 49. Helsinn Healthcare Revenue in Arginase Deficiency Therapeutics Business (2018-2023) & (US$ Million)
Table 50. Helsinn Healthcare Recent Development
Table 51. Novartis Pharmaceuticals Company Detail
Table 52. Novartis Pharmaceuticals Business Overview
Table 53. Novartis Pharmaceuticals Arginase Deficiency Therapeutics Product
Table 54. Novartis Pharmaceuticals Revenue in Arginase Deficiency Therapeutics Business (2018-2023) & (US$ Million)
Table 55. Novartis Pharmaceuticals Recent Development
Table 56. Horizon Pharma Company Detail
Table 57. Horizon Pharma Business Overview
Table 58. Horizon Pharma Arginase Deficiency Therapeutics Product
Table 59. Horizon Pharma Revenue in Arginase Deficiency Therapeutics Business (2018-2023) & (US$ Million)
Table 60. Horizon Pharma Recent Development
Table 61. Medicis Pharmaceutical Company Detail
Table 62. Medicis Pharmaceutical Business Overview
Table 63. Medicis Pharmaceutical Arginase Deficiency Therapeutics Product
Table 64. Medicis Pharmaceutical Revenue in Arginase Deficiency Therapeutics Business (2018-2023) & (US$ Million)
Table 65. Medicis Pharmaceutical Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Arginase Deficiency Therapeutics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Arginase Deficiency Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. Oral Features
Figure 4. Injection Features
Figure 5. Global Arginase Deficiency Therapeutics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Arginase Deficiency Therapeutics Market Share by Application: 2022 VS 2033
Figure 7. Hospital Case Studies
Figure 8. Drugs Stores Case Studies
Figure 9. Other Case Studies
Figure 10. Arginase Deficiency Therapeutics Report Years Considered
Figure 11. Global Arginase Deficiency Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Arginase Deficiency Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Arginase Deficiency Therapeutics Market Share by Region: 2022 VS 2033
Figure 14. Global Arginase Deficiency Therapeutics Market Share by Players in 2022
Figure 15. Global Top Arginase Deficiency Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Arginase Deficiency Therapeutics as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Arginase Deficiency Therapeutics Revenue in 2022
Figure 17. North America Arginase Deficiency Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Arginase Deficiency Therapeutics Market Share by Country (2018-2033)
Figure 19. United States Arginase Deficiency Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Arginase Deficiency Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Arginase Deficiency Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Arginase Deficiency Therapeutics Market Share by Country (2018-2033)
Figure 23. Germany Arginase Deficiency Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Arginase Deficiency Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Arginase Deficiency Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Arginase Deficiency Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Arginase Deficiency Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Arginase Deficiency Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Arginase Deficiency Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Arginase Deficiency Therapeutics Market Share by Region (2018-2033)
Figure 31. China Arginase Deficiency Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Arginase Deficiency Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Arginase Deficiency Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Arginase Deficiency Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Arginase Deficiency Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Arginase Deficiency Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Arginase Deficiency Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Arginase Deficiency Therapeutics Market Share by Country (2018-2033)
Figure 39. Mexico Arginase Deficiency Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Arginase Deficiency Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Arginase Deficiency Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Arginase Deficiency Therapeutics Market Share by Country (2018-2033)
Figure 43. Turkey Arginase Deficiency Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Arginase Deficiency Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Helsinn Healthcare Revenue Growth Rate in Arginase Deficiency Therapeutics Business (2018-2023)
Figure 46. Novartis Pharmaceuticals Revenue Growth Rate in Arginase Deficiency Therapeutics Business (2018-2023)
Figure 47. Horizon Pharma Revenue Growth Rate in Arginase Deficiency Therapeutics Business (2018-2023)
Figure 48. Medicis Pharmaceutical Revenue Growth Rate in Arginase Deficiency Therapeutics Business (2018-2023)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed

Global Arginase Deficiency Therapeutics Market Research Report 2024

Global Arginase Deficiency Therapeutics Market Research Report 2024

By Company

Segment by Application

Table of Content

List of Figure

Select User License

$4200 Single Licence

$6000 Enterprise Licence

$9100 Corporate Licence

Note : All prices in USD

FAQ'S

User License?

Delivery Time?

How do I place an order?

What is the Payment Options?

Is there a discount for multiple purchases?

Mode of Report Delivery?

Top Industries